425 related articles for article (PubMed ID: 28819009)
1. The AAA+ ATPase p97, a cellular multitool.
Stach L; Freemont PS
Biochem J; 2017 Aug; 474(17):2953-2976. PubMed ID: 28819009
[TBL] [Abstract][Full Text] [Related]
2. Common Mode of Remodeling AAA ATPases p97/CDC48 by Their Disassembling Cofactors ASPL/PUX1.
Banchenko S; Arumughan A; Petrović S; Schwefel D; Wanker EE; Roske Y; Heinemann U
Structure; 2019 Dec; 27(12):1830-1841.e3. PubMed ID: 31648844
[TBL] [Abstract][Full Text] [Related]
3. New ATPase regulators--p97 goes to the PUB.
Madsen L; Seeger M; Semple CA; Hartmann-Petersen R
Int J Biochem Cell Biol; 2009 Dec; 41(12):2380-8. PubMed ID: 19497384
[TBL] [Abstract][Full Text] [Related]
4. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
5. VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.
Baron Y; Pedrioli PG; Tyagi K; Johnson C; Wood NT; Fountaine D; Wightman M; Alexandru G
BMC Biol; 2014 May; 12():39. PubMed ID: 24885147
[TBL] [Abstract][Full Text] [Related]
6. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
7. Structure and Function of the AAA+ ATPase p97, a Key Player in Protein Homeostasis.
Hänzelmann P; Galgenmüller C; Schindelin H
Subcell Biochem; 2019; 93():221-272. PubMed ID: 31939153
[TBL] [Abstract][Full Text] [Related]
8. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways.
Chou TF; Brown SJ; Minond D; Nordin BE; Li K; Jones AC; Chase P; Porubsky PR; Stoltz BM; Schoenen FJ; Patricelli MP; Hodder P; Rosen H; Deshaies RJ
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4834-9. PubMed ID: 21383145
[TBL] [Abstract][Full Text] [Related]
9. Inter-ring rotations of AAA ATPase p97 revealed by electron cryomicroscopy.
Yeung HO; Förster A; Bebeacua C; Niwa H; Ewens C; McKeown C; Zhang X; Freemont PS
Open Biol; 2014 Mar; 4(3):130142. PubMed ID: 24598262
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
[TBL] [Abstract][Full Text] [Related]
11. Development of p97 AAA ATPase inhibitors.
Chou TF; Deshaies RJ
Autophagy; 2011 Sep; 7(9):1091-2. PubMed ID: 21606684
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the AAA
Rao MV; Williams DR; Cocklin S; Loll PJ
J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in p97/VCP/Cdc48 cellular functions.
Yamanaka K; Sasagawa Y; Ogura T
Biochim Biophys Acta; 2012 Jan; 1823(1):130-7. PubMed ID: 21781992
[TBL] [Abstract][Full Text] [Related]
14. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
[TBL] [Abstract][Full Text] [Related]
15. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle.
Rouiller I; DeLaBarre B; May AP; Weis WI; Brunger AT; Milligan RA; Wilson-Kubalek EM
Nat Struct Biol; 2002 Dec; 9(12):950-7. PubMed ID: 12434150
[TBL] [Abstract][Full Text] [Related]
16. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
17. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.
Anderson DJ; Le Moigne R; Djakovic S; Kumar B; Rice J; Wong S; Wang J; Yao B; Valle E; Kiss von Soly S; Madriaga A; Soriano F; Menon MK; Wu ZY; Kampmann M; Chen Y; Weissman JS; Aftab BT; Yakes FM; Shawver L; Zhou HJ; Wustrow D; Rolfe M
Cancer Cell; 2015 Nov; 28(5):653-665. PubMed ID: 26555175
[TBL] [Abstract][Full Text] [Related]
18. Interprotomer motion-transmission mechanism for the hexameric AAA ATPase p97.
Li G; Huang C; Zhao G; Lennarz WJ
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3737-41. PubMed ID: 22355145
[TBL] [Abstract][Full Text] [Related]
19. The PUB domain functions as a p97 binding module in human peptide N-glycanase.
Allen MD; Buchberger A; Bycroft M
J Biol Chem; 2006 Sep; 281(35):25502-8. PubMed ID: 16807242
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an Additional Binding Surface on the p97 N-Terminal Domain Involved in Bipartite Cofactor Interactions.
Hänzelmann P; Schindelin H
Structure; 2016 Jan; 24(1):140-147. PubMed ID: 26712280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
